TSX:REUN - Post Discussion
Post by
Betteryear2 on Apr 28, 2022 6:24pm
Field Trip Health Ltd. Announces Intention
- Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies.
- Shareholders of Field Trip will receive shares of each company.
- Company to host a conference call on Friday, April 29, 2022 at 8:30 a.m. ET.
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (the "Company"), a global leader in the development and delivery of psychedelic therapies, announced today that it has received unanimous board approval to complete a reorganization that will result in the separation of its Field Trip Discovery and Field Trip Health divisions into two independent public companies (the "Transaction"). Field Trip Discovery will be renamed Reunion Neuroscience Inc. (“Reunion”) and Field Trip Health will be renamed Field Trip Health and Wellness Ltd. (“Field Trip H&W”). Concurrent with closing of the Transaction, Field Trip H&W is expected to complete financings for gross proceeds of approximately C$20 million led by Oasis Management Company and the Company (the “Financings”).
Be the first to comment on this post